this is hero image

Contact Us

Please complete your contact details below and an Ascensia Diabetes Care representative will follow up with you shortly to provide more information on Eversense or discuss your inquiry.

Interested in learning more about how Eversense can help your diabetes patients?

Please complete your contact details and an Ascensia Diabetes Care representative will follow up with you shortly to discuss your inquiry.
Please provide your direct contact details to prevent any delays in response.
*Indicates required field.

Thank you.

We have receieved your message.

A general error occurred. Please try again later.

How can we help you?

Contact Information

By clicking 'Submit' you confirm that you are allowed to provide this information and that you have carefully read our Privacy Policy and understood how we may process your health-related information. By clicking submit you consent to being contacted by Ascensia Diabetes Care.

Chris

“I love the removable transmitter.* I’m clumsy, things happen - I can bump into something, take my shirt off too fast, or I can be crazy in the gym. If the corner of the adhesive starts to peel up or something happens, I just put the transmitter back or use a new adhesive. It doesn’t stop my whole life.”

PLAY VIDEO
Matt

“The accuracy that I get from Eversense and the predictive alerts allows me to really maintain that time in-range, and I’ve seen that improve year over year as I continue to use the product.”

PLAY VIDEO
Mary

“My daily life has changed having Eversense. When I travel, I just grab my stuff and go. I don’t have to think about packing [sensors] when I leave.” 

PLAY VIDEO
Dianne

“Two words: Life changing. Having Eversense, I am less anxious, I’m much more productive, and I’m much happier.”

PLAY VIDEO

*There is no glucose data generated when the transmitter is removed

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

PP-SENS-E3-GBL-0062